Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I Study of PTK/ZK in Combination With Pemetrexed Disodium (ALIMTA)

Trial Profile

Phase I Study of PTK/ZK in Combination With Pemetrexed Disodium (ALIMTA)

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 31 Oct 2018

At a glance

  • Drugs Vatalanib (Primary) ; Pemetrexed
  • Indications Colorectal cancer; Germ cell and embryonal neoplasms; Head and neck cancer; Liver cancer; Non-small cell lung cancer; Prostate cancer; Small cell lung cancer; Solid tumours
  • Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 31 Oct 2018 Results published in the Investigational New Drugs
    • 05 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 05 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top